At a Glance

• Dr. Isabella Caniggia investigates the causes and detection of preeclampsia and works to improve placental health in expectant mothers
• Her lab has made great strides in identifying genetic alterations that predict if pregnant women will have early or late onset preeclampsia
• Recently licensed biomarker findings to help develop a diagnostic tool that will detect and manage preeclampsia in expectant mothers
• Did you know…? That pre-eclampsia effects 7-10% of all pregnancies and is the leading cause of fetal and mother mortality and morbidities

Major Research Activities

Identifying genetic alterations, or biomarkers, that predict whether pregnant women will have early- or late-onset preeclampsia.

Recent Publications

► Lunenfeld Research Repository